{"companyId":287236,"requestedLanguage":"en","resolvedLanguage":"en","availableLanguages":["en","ja"],"companyName":"Arecor Therapeutics plc","headOfficeLocation":"Chesterford Research Park, Little Chesterford, Saffron Walden CB10 1XL, United Kingdom","presidentName":"Dr Sarah Howell","companySummary":null,"stockCode":"AREC","currency":"GBP","capital":null,"sales":null,"employees":null,"employeesConsolidated":null,"humanCheck":false,"domains":["arecor.com"],"businessContents":["Therapeutic development","Diabetes drug development","Biopharmaceutical formulation","Cardiometabolic therapeutics"],"relations":[],"dataSources":[{"detailNumber":1,"url":"https://arecor.com/investor-centre/aim-rule-26/","scoreAbout":300,"scoreBusiness":200,"scoreGroup":0,"scoreCustomer":0},{"detailNumber":2,"url":"https://arecor.com/investor-centre/shareholder-information/","scoreAbout":300,"scoreBusiness":200,"scoreGroup":0,"scoreCustomer":0},{"detailNumber":3,"url":"https://find-and-update.company-information.service.gov.uk/company/13331147","scoreAbout":300,"scoreBusiness":100,"scoreGroup":0,"scoreCustomer":0}]}